Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia.

Rothbard AB, Kuno E, Foley K.

Schizophr Bull. 2003;29(3):531-40.

PMID:
14609246
2.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC.

J Clin Psychiatry. 2004 Oct;65(10):1377-88.

PMID:
15491242
4.

Effects of antipsychotic medication on psychiatric service utilization and cost.

Rothbard A, Murrin MR, Jordan N, Kuno E, McFarland BH, Stroup TS, Morrissey JP, Stiles PG, Boothroyd RA, Merwin E, Shern DL.

J Ment Health Policy Econ. 2005 Jun;8(2):83-93.

PMID:
15998980
5.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
6.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

7.

Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Schizophr Bull. 2004;30(2):255-64.

PMID:
15279044
8.

[Clinical and socio-demographic profile of patients with schizophrenia according to the antipsychotic treatment prescribed].

Lamarque I, Auffray L, Villamaux M, Demant JC, Launay C, Petitjean F, Salomé F.

Encephale. 2006 May-Jun;32(3 Pt 1):369-76. French.

PMID:
16840931
9.

Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.

Aparasu RR, Jano E, Johnson ML, Chen H.

Am J Geriatr Pharmacother. 2008 Oct;6(4):198-204. doi: 10.1016/j.amjopharm.2008.10.003.

PMID:
19028375
10.

Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.

Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):412-20.

PMID:
16287199
11.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
12.
13.

How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience.

Dewa CS, Remington G, Herrmann N, Fearnley J, Goering P.

Clin Ther. 2002 Sep;24(9):1466-76.

PMID:
12380638
15.
16.
17.
18.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
19.

Antipsychotic medication utilization trends among Texas veterans: 1997-2002.

Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA.

Ann Pharmacother. 2008 Sep;42(9):1229-38. doi: 10.1345/aph.1L155. Epub 2008 Aug 5.

PMID:
18682544
20.

Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.

Diatta T, Blazejewski S, Portier A, Lignot S, Quesnot A, Moore N, Fourrier-Réglat A.

Fundam Clin Pharmacol. 2007 Aug;21(4):371-8.

PMID:
17635175

Supplemental Content

Support Center